Company Filing History:
Years Active: 2024
Title: Celebrating the Innovations of Inventor Magdalena Kieltyka
Introduction: Magdalena Kieltyka, based in Oxfordshire, GB, is a noteworthy inventor known for her contributions to the field of biotechnology. With her keen insights and innovative spirit, she has made meaningful advancements, particularly in formulations that hold potential for the treatment of serious health conditions such as cancer.
Latest Patents: Magdalena holds a patent for a liquid formulation suitable for a group B adenovirus. This formulation comprises several key components: a group B adenovirus, a concentration of glycerol ranging from 15% to 25% v/v, ethanol in the range of 0.1% to 1.5% v/v, and a buffer. Notably, the pH of the formulation is maintained between 8.0 to 9.6, enhancing its applicability in medical treatments. Her innovation indicates a promising approach towards cancer therapy.
Career Highlights: At present, Magdalena is associated with Akamis Bio Limited, where she applies her expertise in biotechnology and formulation development. Her role involves innovation in therapeutic applications, reflecting her dedication to improving patient health outcomes.
Collaborations: Throughout her career, Magdalena has collaborated with esteemed scientists and researchers, including her coworker Simon Alvis. This teamwork fosters an environment of shared knowledge and creativity, leading to significant advancements in the field of biotechnology.
Conclusion: Magdalena Kieltyka stands out as a pioneering inventor dedicated to the exploration of innovative treatments utilizing adenoviral formulations. Her patent represents a critical step forward in cancer treatment, and her contributions to Akamis Bio Limited exemplify her commitment to scientific advancement and improving healthcare.